Long-COVID and loss of smell: A post-COVID olfactory dysfunction that continues to challenge the allergist/immunologist.
作者信息
Bellanti Joseph A, Settipane Russell A
出版信息
Allergy Asthma Proc. 2022 Mar 1;43(2):93-95. doi: 10.2500/aap.2022.43.220008.
Abstract
摘要
相似文献
1
Long-COVID and loss of smell: A post-COVID olfactory dysfunction that continues to challenge the allergist/immunologist.
Allergy Asthma Proc. 2022 Mar 1;43(2):93-95. doi: 10.2500/aap.2022.43.220008.
2
The Importance of Considering Olfactory Dysfunction During the COVID-19 Pandemic and in Clinical Practice.
J Allergy Clin Immunol Pract. 2021 Jan;9(1):7-12. doi: 10.1016/j.jaip.2020.10.036. Epub 2020 Oct 28.
3
Parosmia after COVID-19: olfactory training, neuroinflammation and distortions of smell.
Eur Rev Med Pharmacol Sci. 2022 Jan;26(1):1-3. doi: 10.26355/eurrev_202201_27739.
4
Olfactory training for olfactory dysfunction in COVID-19: A promising mitigation amidst looming neurocognitive sequelae of the pandemic.
Clin Exp Pharmacol Physiol. 2022 Apr;49(4):462-473. doi: 10.1111/1440-1681.13626. Epub 2022 Feb 10.
5
Implementing a COVID-19 specialist smell clinic: experience at the Wrightington, Wigan and Leigh Teaching Hospitals (WWL), NHS Foundation Trust, United Kingdom.
Med J Malaysia. 2021 Aug;76(Suppl 4):9-13.
6
Sociodemographic Characteristics and Comorbidities of Patients With Long COVID and Persistent Olfactory Dysfunction.
JAMA Netw Open. 2022 Sep 1;5(9):e2230637. doi: 10.1001/jamanetworkopen.2022.30637.
7
[Loss of smell, a preliminary indicator of COVID-19].
Rev Med Inst Mex Seguro Soc. 2021 Feb 2;59(1):4-6. doi: 10.24875/RMIMSS.M21000046.
8
In response to Intranasal Corticosteroid Treatment on Recovery of Long-Term Olfactory Dysfunction Due to COVID-19.
Laryngoscope. 2023 Apr;133(4):E31. doi: 10.1002/lary.30506. Epub 2022 Dec 10.
9
Olfactory Dysfunction in COVID-19 Patients: Prevalence and Prognosis for Recovering Sense of Smell.
Otolaryngol Head Neck Surg. 2021 Jan;164(1):82-86. doi: 10.1177/0194599820943530. Epub 2020 Jul 14.
10
Anosmia: an evolution of our understanding of its importance in COVID-19 and what questions remain to be answered.
Eur Arch Otorhinolaryngol. 2021 Jul;278(7):2187-2191. doi: 10.1007/s00405-020-06285-0. Epub 2020 Sep 9.
引用本文的文献
1
From Acute Phase to Long COVID: A Cross-Sectional Study of the Epidemiological Profile and Clinical Evaluation of SARS-CoV-2 Infection in Employees at a Pediatric Hospital.
J Clin Med. 2023 Jun 27;12(13):4325. doi: 10.3390/jcm12134325.
2
A confluence of advanced treatment options for atopic dermatitis, eosinophilic lung diseases and chronic urticaria brought about by the revolutionary discovery of biologics and Janus kinase inhibitors.
Allergy Asthma Proc. 2022 Nov 1;43(6):471-473. doi: 10.2500/aap.2022.43.220081.
3
Asthma biomarkers and COVID-19 continue to dominate current medical issues.
Allergy Asthma Proc. 2022 Sep 1;43(5):363-367. doi: 10.2500/aap.2022.43.220062.
4
Eosinophilic esophagitis: from discovery to effective treatment.
Allergy Asthma Proc. 2022 May 1;43(3):175-177. doi: 10.2500/aap.2022.43.220025.
本文引用的文献
1
Cost assessment of allergy procedures to improve high-value care implementation.
Allergy Asthma Proc. 2022 Mar 1;43(2):168-172. doi: 10.2500/aap.2022.43.210115.
2
Female sex as a risk factor for penicillin drug allergy in the inpatient setting.
Allergy Asthma Proc. 2022 Mar 1;43(2):163-167. doi: 10.2500/aap.2022.43.210002.
3
Initial characteristics and follow-up of patients with a diagnosis of angiotensin-converting enzyme inhibitor induced angioedema.
Allergy Asthma Proc. 2022 Mar 1;43(2):155-162. doi: 10.2500/aap.2022.43.220005.
4
How satisfactory is on-demand icatibant from the patients' perspective in real life?
Allergy Asthma Proc. 2022 Mar 1;43(2):148-154. doi: 10.2500/aap.2022.43.210104.
5
Impact of socioeconomic factors and house cleaning on asthma control in women.
Allergy Asthma Proc. 2022 Mar 1;43(2):140-147. doi: 10.2500/aap.2022.43.210003.
6
Eosinophil-derived neurotoxin: An asthma exacerbation biomarker in children.
Allergy Asthma Proc. 2022 Mar 1;43(2):133-139. doi: 10.2500/aap.2022.43.210001.
7
Profiles of sensitization and comorbidity in asthma patients with markedly increased serum total IgE (>1000kU/L).
Allergy Asthma Proc. 2022 Mar 1;43(2):124-132. doi: 10.2500/aap.2022.43.210123.
8
Birch-naive, oak-allergic subjects' response to birch pollen in an environmental chamber.
Allergy Asthma Proc. 2022 Mar 1;43(2):116-123. doi: 10.2500/aap.2022.43.210097.
9
Clinical effects of intranasal corticosteroids on nasal symptoms in subjects with chronic rhinitis during COVID-19.
Allergy Asthma Proc. 2022 Mar 1;43(2):106-115. doi: 10.2500/aap.2022.43.210116.
10
Treatment strategies for postviral olfactory dysfunction: A systematic review.
Allergy Asthma Proc. 2022 Mar 1;43(2):96-105. doi: 10.2500/aap.2022.43.210107.
Zotero 插件